coagulation factor V ; Homo sapiens






97 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 49986 [Inhibition of viral reverse transcriptase and leukemogenesis by modified nucleic acids (author's transl)]. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol 1975 1
2 2168225 Sulfation of tyrosine residues in coagulation factor V. Blood 1990 Sep 1 3
3 2236295 Fractionation and characterization of mitogenic and anti-complementary active fractions from kampo (Japanese Herbal) medicine "juzen-taiho-to". Planta Med 1990 Aug 2
4 3944265 Isolation and study of an acquired inhibitor of human coagulation factor V. J Clin Invest 1986 Feb 2
5 4015398 Phthalates and organophosphorus compounds as cholinesterase inhibitors in fractions of industrial hexane impurities. Arch Toxicol 1985 Apr 1
6 7076681 Thrombin-catalyzed activation of human coagulation factor V. J Biol Chem 1982 Jun 10 2
7 7631299 Studies on phospholipid antibodies, APC-resistance and associated mutation in the coagulation factor V gene. Thromb Res 1995 May 1 1
8 7653875 [Optimization of artificial pulmonary ventilation in patients with organophosphorus compound poisoning complicated by development of exotoxic shock]. Anesteziol Reanimatol 1995 May-Jun 1
9 8571340 APC-resistance and Mnl I genotype (Gln 506) of coagulation factor V are rare in Japanese population. Thromb Haemost 1995 Sep 1
10 8589213 No association of APC resistance with myocardial infarction. Blood Coagul Fibrinolysis 1995 Jul 1
11 8645525 [Arg506 --> Gln mutation of coagulation factor V (factor V Leiden) and transient cerebral ischemia at a young age in 3 members of the same family]. Ann Ital Med Int 1996 Jan-Mar 1
12 8745708 [Retinal vein occlusion and resistance to activated protein C]. J Fr Ophtalmol 1995 2
13 8819251 Mutation in the gene coding for coagulation factor V and resistance to activated protein C: detection of the genetic mutation by oligonucleotide ligation assay using a semi-automated system. Thromb Haemost 1996 Jul 1
14 8902986 A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects. Thromb Haemost 1996 Oct 1
15 9149031 Tamoxifen-associated venous thrombosis and activated protein C resistance due to factor V Leiden. Cancer 1997 May 15 2
16 9289995 [Physical features of high-frequency artificial ventilation of lungs]. Anesteziol Reanimatol 1997 May-Jun 1
17 9432898 [The problem of airtightness during the use of a laryngeal mask under conditions of carboperitoneum and muscle relaxation]. Anesteziol Reanimatol 1997 Sep-Oct 1
18 9693433 [Effects of ventilation of the lungs in prone position on the pulmonary oxygenation function and hemodynamic parameters of heart surgery patients with respiratory insufficiency in the postoperative period]. Anesteziol Reanimatol 1998 May-Jun 1
19 9716141 Coagulation factor V (Arg506-->Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting. Thromb Haemost 1998 Aug 1
20 9855272 Portal and mesenteric vein thrombosis in a patient heterozygous for a mutation (Arg506-->Gln) in the factor V gen (factor V Leiden). J Clin Gastroenterol 1998 Dec 1
21 10097286 Mechanisms that regulate the anticoagulant function of coagulation factor V. Scand J Clin Lab Invest Suppl 1999 4
22 10402408 The factor V Leiden mutation in Japanese couples with recurrent spontaneous abortion. Hum Reprod 1999 Jul 1
23 10521265 Partial glycosylation of Asn2181 in human factor V as a cause of molecular and functional heterogeneity. Modulation of glycosylation efficiency by mutagenesis of the consensus sequence for N-linked glycosylation. Biochemistry 1999 Oct 12 1
24 10598348 [Resistance to activated protein C and pregnancy: thromboprophylaxis with low molecular weight heparin]. J Gynecol Obstet Biol Reprod (Paris) 1999 Oct 2
25 10636214 The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis. J Clin Gastroenterol 2000 Jan 1
26 10926882 Genotyping of factor V G1691A (Leiden) without the use of PCR by invasive cleavage of oligonucleotide probes. Clin Chem 2000 Aug 1
27 10928623 Detection of factor V Leiden in Thai patients with venous thrombosis. Asian Pac J Allergy Immunol 2000 Jun 1
28 11586621 [Brain protection in open heart surgery in patients with infective endocarditis]. Anesteziol Reanimatol 2001 Jul-Aug 1
29 11593787 [From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A]. Ned Tijdschr Geneeskd 2001 Sep 22 2
30 11683790 Warfarin-induced skin necrosis associated with Factor V Leiden and protein S deficiency. Clin Lab Haematol 2001 Aug 1
31 11733730 [Evaluation of resistance to activated protein C in myocardial infarction patients]. Minerva Cardioangiol 2001 Dec 2
32 11760675 [Neonatal renal vein thrombosis in a heterozygous carrier of both factor V Leiden and prothrombin mutations]. Arch Pediatr 2001 Nov 1
33 11914653 A matrix-assisted laser desorption/ionization time-of-flight based method for screening the 1691G --> A mutation in the factor V gene. Blood Coagul Fibrinolysis 2002 Mar 1
34 15135449 Four-color multiplex 5' nuclease assay for the simultaneous detection of the factor V Leiden and the prothrombin G20210A mutations. Mol Cell Probes 2004 Jun 1
35 15199491 Congenital and acquired activated protein C resistance. Semin Vasc Med 2003 Feb 2
36 15374562 Epidural blood patch in a patient taking enoxaparin. J Clin Anesth 2004 Aug 1
37 16045879 [Benign intracranial hypertension and heterozygosity for factor V Leiden mutation]. An Pediatr (Barc) 2005 Aug 1
38 16450127 Thrombophilic mutations in Iranian patients with infertility and recurrent spontaneous abortion. Ann Hematol 2006 Apr 1
39 16471711 Intramolecular electron transfer in cofacially pi-stacked fluorenes: evidence of tunneling. J Phys Chem B 2006 Feb 2 2
40 16818854 Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial. J Natl Cancer Inst 2006 Jul 5 2
41 17146542 [Stroke: epidemiology, risk factors, and genetics]. Hamostaseologie 2006 Nov 1
42 17200768 No interaction between factor V Leiden and hyperhomocysteinemia or MTHFR 677TT genotype in venous thrombosis. Results of a meta-analysis of published studies and a large case-only study. Thromb Haemost 2007 Jan 1
43 17269939 Molecular characterization and subcellular localization of Tyr478del: a pathogenic in-frame deletion in coagulation factor V. J Thromb Haemost 2007 Feb 1
44 17390701 In situ-formed asymmetric membrane capsule for osmotic release of poorly water-soluble drug. PDA J Pharm Sci Technol 2007 Jan-Feb 2
45 17721328 CYP2C9 and VKORC1 genetic polymorphism analysis might be necessary in patients with Factor V Leiden and prothrombin gene G2021A mutation(s). Diagn Mol Pathol 2007 Sep 1
46 18217158 Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study. Thromb Haemost 2008 Jan 1
47 18290319 Separation of Factor V Leiden molecule, a mutated form of Factor V, from plasma of homozygous patient. Adv Exp Med Biol 2008 3
48 18641556 Pharmacokinetic-pharmacodynamic assessment of tacrolimus in liver-transplant recipients during the early post-transplantation period. Ther Drug Monit 2008 Aug 1
49 18948369 Prediction of recurrent venous thromboembolism by endogenous thrombin potential and D-dimer. Clin Chem 2008 Dec 1
50 19003790 Multimodal architectonic subdivision of the rostral part (area F5) of the macaque ventral premotor cortex. J Comp Neurol 2009 Jan 10 1